Background: Opioids are commonly prescribed to manage cancer pain. Similar to the general population, patients with cancer are not excluded from the risk for opioid misuse and dependence. This situation can contribute to clinician reluctance to prescribe and manage pain using opioids. Objectives:...

Background: The administration of granulocyte–colony-stimulating factors (G-CSFs) has proven to be essential in increasing the body’s immune system following treatment with chemotherapy; however, many patients have reported varying levels of acute bone pain after receiving G-CSFs. Objectives: The...

Hematologic B-cell malignancies, which have varying behavior patterns, disease processes, and treatment responses, include non-Hodgkin lymphoma, leukemias, and myeloma. Although monoclonal antibodies and other agents have led to dramatic advances in the treatment of B-cell malignancies, the...

Background: Young women with breast cancer (YWBC) are more likely to have aggressive disease, carry mutations for hereditary cancer genes, and experience higher mortality. They also may face reduced fertility because of the toxicity of chemotherapy. Objectives: This article aims to present a review...